Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP

American Journal of Gastroenterology

Volumn 102, Issue 5, 2007, Pages 978-983

  Sotoudehmanesh, Rasoul ^a   Khatibian, Morteza ^a   Kolahdoozan, Shadi ^a   Ainechi, Sanaz ^a   Malboosbaf, Ramin ^a   Nouraie, Mehdi ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; INDOMETACIN; PLACEBO;

ACUTE PANCREATITIS; ADULT; AGE DISTRIBUTION; AMYLASE BLOOD LEVEL; ARTICLE; CANNULATION; CHOLANGIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; INCIDENCE; INJECTION; MALE; PANCREAS DUCT; PANCREATOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHI-SQUARE DISTRIBUTION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; INDOMETHACIN; MALE; MIDDLE AGED; PANCREATITIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34247889840     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01165.x     Document Type: Article

References (21)

1. Rabenstein T, Hahn EG. Post-ERCP pancreatitis: New momentum. Endoscopy 2002 34 : 325 9.
2. Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002 56 : 652 6.
3. Whitcomb DC. Acute pancreatitis: Molecular biology update. J Gastrointest Surg 2003 7 : 940 2.
4. Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines-new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993 40 : 522 30.
5. The burden of gastrointestinal diseases. Bethesda : MD America Gastroenterological Association, 2001 : 48 50.
6. Masci E, Cavallini G, Mariani A, et al. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol 2003 98 : 2182 6.
7. Andriulli A, Solmi L, Loperfido S, et al. Prophylaxis of ERCP-related pancreatitis: A randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2004 2 : 713 8.
8. Chen SY, Wang JY. Shanghai Collaboration Group on Ulinastatin Clinical Trials: Ulinastatin in the treatment of acute pancreatitis: A multicenter clinical trial. Chin J Dig Dis 2002 3 : 70 5.
9. Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: A meta-analysis. Gastrointest Endosc 2000 51 : 1 7.
10. Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002 56 : 488 95.
11. Makela A, Kuusi T, Schroder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest 1997 57 : 401 7.
12. Wildenhain PM, Melhem MF, Birsic WI, et al. Acute hemorrhagic pancreatitis in mice: Improved survival after indomethacin administration. Digestion 1989 44 : 41 51.
13. Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003 124 : 1786 91.
14. Moreto M, Zaballa M, Casado I, et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial. Gastrointest Endosc 2003 57 : 1 7.
15. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: A comprehensive review. Gastrointest Endosc 2004 59 : 845 64.
16. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991 37 : 383 93.
17. Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy 1988 20 (Suppl 1 179 83.
18. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: A prospective multicenter study. Am J Gastroenterol 2001 96 : 417 23.
19. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001 54 : 425 34.
20. Aliperti G. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am 1996 6 : 379 407.
21. Tarnasky PR, Palesch YY, Cunningham JT, et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998 115 : 1518 24.